Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Pluvicto 1,000 MBq/mL solution for injection/infusion {equilateral_black_triangle}

Active Ingredient:
lutetium (177Lu) vipivotide tetraxetan
Company:  
Novartis Pharmaceuticals UK Ltd See contact details
ATC code: 
V10XX05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Live Chat HCP Med Info
{arrow_left}
{arrow_right}

This chat facility is provided by the company that holds the marketing authorisation for the medicine


Click here to connect to Chat

Click to Chat is a service provided for healthcare professionals, you can use the chat facility to contact Novartis about prescription only medicines.

If you are unable to get through to a live agent, please contact Novartis Medical Information via:

Email: [email protected]

Telephone: 01276698370
Novartis Pharmaceuticals UK Ltd
Company image
Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Telephone
+44 (0)1276 692 255
Medical Information Direct Line
+44 (0)1276 698 370
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)845 741 9442
E-mail
[email protected]